1 Shechter Y, Goldwaser I, Mironchik M, Fridkin MT, Gefel D.Historic perspective and recent developments on the insulin-like actions of vanadium;toward developing vanadium-based drugs for diabetes[J].Coord Chem Rev , 2003;237:3-11
2 Coderre L, Srivastava AK.Vanadium and the cardiovascular functions[J].Can J Phy siol Pharmacol, 2004;82:833-9
3 Crans DC, Smee JJ, Gaidamauskas E, Yang L.The chemistry and Biochemistry of vanadium and the biological activities exerted by banadium compounds[J].Chem Rev , 2004;104:849-902
4 ucheret P, Verma S, Grynpas MD, MeNeill JH.Vanadium and diabetes[J].Mol Cell Biochem , 1998;188:73-80
5 Mukherjee B, Patra B, Mahapatra PJ, Tiwari A, Chatterjee M.Vanadium-an element of atypical biological significance [J].Toxicol Lett, 2004;150:135-43
6 Byrne AR, kosta L.Vanadium in food and human body fluids and tissues[J].Sci Total Environ , 1993;9:17-30
7 Schechter Y, Karlish SJD.Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl(Ⅳ)[J].Nature , 1980;284:556-8
8 Li J, Elberg G, Crans DC, Shechter Y.Evidences for the distinct vanadyl (+4)-dependent activating system for manifesting insulin-like effects[J].Biochemistry , 1996;35:8314-28
9 Heyliger CE., Tahiliani AG, McNeill JH.Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats[J].Science , 1985;227:1474-7
10 Shisheva A, ShichterY.Quercetin selectively inhibits insulin receptor function in vitro and the bioresponses of insulin and insulinomeimetic agents in rat adipocytes [J].Biochemistry , 1992;31:8059-63
11 Shisheva A, Shichter Y.A cytosolic protein tyrosine kinase in rat adipocytes[J].FEBS Lett , 1992;300:93 -6 12 Shechter Y, Shechter Y.Role of cytosolic tyrosine kinase in mediating the insulin like actions of vanadate in rat adipocytes[J].J Biol Chem , 1993;268:6463-9
12 Elberg G, Li J, Shechter Y.Vanadium activates or inhibits receptor and non-receptor protein tyrosine kinases in cell-free experiments, depending on its oxidation state[J].J Biol Chem,1994;269:9521-7
13 Elberg G, Li J, Leibovitch A, Shechter Y.Non-receptor cytosolic protein tyroxine kinase from various rat tissues[J].Biochem Biophy s Acta , 1995;1269:299-306
14 Li J, Elberg G, Sekar N, He ZB, Shechter Y.Antilipolytic actions of vanadate and insulin in rat adipocytes mediated by distinctly different mechanisms[J].J Endocrinology , 1997;138:2274-9
15 Goldfine AB, Simonson DC, Folli F, Patti ME, Khan CR.Metabolic effects of sodium metavanadate in humans with insulin-dependent and non insulin dependent diabetes mellitus in vivo and in vitro studies[J].J Clin Endocrinol Metab , 1995;80:3311-20
16 Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rossetti L.Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non insulin dependent diabetes mellitus[J].J Clin Invest, 1995;95:2501-9
17 Willsky GR, Goldfine AB, Kostyniak PJ, McNeill JH, Yang LQ, Khan HR, et al.Effect of vanadium (Ⅳ)compounds in the treatment of diabetes:in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovanadium (Ⅳ)[J].J Inorganic Biochemistry , 2001;85:33-42
18 Badmaev V, prakash S, Majeed M.Vanadium:a review of its potential role in the fight against diabetes[J].J Altern Complement Med, 1999;5:273-91
19 Sekar N, Li J, Schechter Y.Vanadium salts as insulin substitutes:Mechanism of action, a scientific and therapeutic tool in diabetes mellitus research[J].Critical Rev Biochem Mol Biol,1996;31:339-59
20 Nechay BR.Mechanism of action of vanadium[J].Ann Rev Pharmacol Toxicol, 198;24:501-24
21 Srivastava AK.Anti-diabetic and toxic effects of vanadium compounds[J].Mol Cell Biochem, 2000;206:177-82
22 任来春, 李杰, 程丽梅.原钒酸钠对大鼠的毒性及1 , 2-二羟基苯3 , 5 二磺酸钠对钒蓄积和排泄的影响[J].卫生毒力学杂志, 2002;3:33-5
23 Facchini DM, Yuen VG, Battel ML, McNeill JH, Grynpas MD.The effects of vanadium trentment on bone in diabetic and non-diabetic rats[J].Bone , 2006;38:368-77 |
